CD44 Expression in Human Meningiomas: An Immunohistochemical Analysis

Polish Journal of Pathology

Volumn 55, Issue 1, 2004, Pages 33-37

  Lewy Trenda, Iwona ^a,b   Omulecka, Aleksandra ^a   Janczukowicz, Janusz ^a   Papierz, Wielisław ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Department of Pathomorphology ^*  (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HERMES ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MORPHOMETRICS;

ADULT; AGED; ANTIGENS, CD44; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 2342477649     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ariza A, Lopez D, Mate JL, Isamat M, Musulen E, Pujol M, Ley A, Navas-Palacios JJ: Role of CD44 in the invasiveness of glioblastoma multiforme and the non-invasiveness of meningioma: an immunohistochemistry study. Hum Pathol 1995, 26, 1144-1147.
2. Favort MC, Combaret V, Lasset C: CD44 - a new prognostic marker for neuroblastoma. N Engl J Med 1993, 329, 1965.
3. Figarella-Branger D, Roche PH, Daniel L, Dufour H, Bianco N, Pellissier JF: Cell-adhesion molecules in human meningiomas: correlation with clinical and morphological data. Neuropath Appl Neurobiol 1997, 23, 113-122.
4. Fox S, Fawcett J, Jackson D et al: Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 1994, 54, 4539-4546.
5. Fox S, Gatter K, Jacson D et al: CD44 and cancer screening. Lancet 1993, 342, 548-549.
6. Gross N, Beck D, Beretta C, Jackson D, Peruisseau G: CD44 expression and modulation on human neuroblastoma tumors and cell lines. Eur J Cancer 1996, 31A, 471-475.
7. Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D: CD44H expression by human neuroblastoma cells: reaction to mycN amplification and lineage differentiation. Cancer Res 1994, 54, 4238-4242.
8. Harwood CA, Green MA, Cook MG: CD44 expression in melanotic lesions: a marker of malignant progression? Br J Dermatol 1996, 135, 876-882.
9. Heider KH, Dammrich J, Skroch-Angel P, Muller-Hermelink HK, Vollmers P, Herrlich P, Ponta H: Differentiated expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993, 53, 4197-4203.
10. Hsieh H F, Yu JC, Ho LI, Chiu SC, Harn HJ: Molecular studies into the role of CD44 variants in metastasis in gastric cancer. J Clin Pathol: Mol Pathol 1999, 52, 25-28.
11. Humphrey G, Hazel DL, MacLennan K, Lewis I: Expression of CD44 by rhabdomyosarcoma: a new prognostic marker? Brit J Cancer 1999, 80, 918-921.
12. Kahara N, Ozaki T, Doi T, Nishids K, Kawai A, Shibahara M, Inoue H: CD44 expression in soft tissue sarcomas. Virchows Archiv 2000, 436, 574-578.
13. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 1993, 54, 271-335.
14. Lipponen P, Aaltoma V, Kosma VM, Ala-Opas M, Eskelnen M: Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumors and their relation to prognosis during a long-term follow-up. J Pathol 1998, 186, 157-164.
15. Mackay C, Terpe HJ, Stauder R et al: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994, 124, 71-82.
16. Mayer B, Jauch KW, Gunthert U, Figdor CG, Schilberg FW, Funke I, Johnson JP: De novo expression of CD44 and survival in gastric cancer. Lancet 1993, 342, 1019-1022.
17. Nagabhushan M, Ptetlow TG, Guo Y-J, Amini SB, Pretlow T, Sy M-S: Altered expression of CD44 in human prostate cancer during progression. Am J Clin Pathol 1996, 106, 647-651.
18. Regauer S, Ott A, Berghold A, Beham A: CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumor stage? J Pathol 1999, 187, 184-190.
19. Rooprai HK, Liyanage K, King A, Davies D, Martin K, Pilkington GJ: CD44 expression in human meningiomas: An immunocytochemical, immunohistochemical and flow cytometric analysis. Int J Oncol 1999, 14, 855-860.
20. Saegusa M, Hashimura M, Machida D, Okayasu I: Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumors. J Pathol 1999, 187, 173-183.
21. Saegusa M, Machida D, Hashimura M, Okayasu I: CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumor development and progression. J Pathol 1999, 189, 326-337.
22. Sneath RJS, Mangham DC: The normal structure and function of CD44 and its role in neoplasia. J Clin Pathol: Mol Pathol 1998, 51, 191-200.
23. Soughagate J, Tredojdosiewicz LK, Smith B, Selby PJ: Patterns of splice variant and CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines. Int J Cancer 1995, 62, 449-456.
24. Sy MS, Guo YJ, Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 1991, 174, 859-866.
25. Terpe HJ, Christiansen H, Gonzalez M, Berthold F, Lampert F: Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s. Eur J Cancer 1995, 31A, 549-552.
26. Terpe HJ, Zimmer C, Gunthert U, Korf B: CD44 expression in human brain tumors. Clin Neuropathol 1993, 12, 271-272.